Chemical Structure (Qelbree 01)
Qelbree Capsule, Extended Release
Product Images NDC 17772-131
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Qelbree (NDC 17772-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Supernus Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Qelbree 02)
This text is a table showing various levels of hepatic and renal impairment and their effect on pharmacokinetics (PK). The table lists parameters like Cmax and auc, and demonstrates fold change and 90% confidence intervals for each level of impairment. It appears to be related to drug dosing in special populations.*
Figure 2 (Qelbree 03)
Figure 3 (Qelbree 04)
Principal Display Panel (100 mg Capsule Bottle Label)
This is a description for a medication called Qelbree, which comes in the form of extended-release capsules. The recommended dosage is once daily and it is taken orally. The bottle contains 30 capsules and can be identified by the NDC number 17772-131-30. Instructions to dispense the accompanying medication guide to each patient is a requirement.*
Principal Display Panel (150 mg Capsule Bottle Label)
This seems to be a description of a medication called Qelbree in the form of extended-release capsules. It comes in a package containing 30 capsules with the NDC code 17772-132-30. The medication is taken orally once daily and is accompanied by a medication guide that should be given to each patient by the dispensing pharmacist. The remaining text consists of a code and some symbols.*
Principal Display Panel (200 mg Capsule Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
